Real-Time Post-Market Signal For Enhanced Surveillance - HHS

The U.S. Food and Drug Administration (FDA) is conducting market research to better understand industry capabilities related to providing real-time or near-real-time signals that may support FDA’s post-market surveillance activities for regulated products. FDA is interested in learning whether commercial organizations currently provide, or could provide, timely signals or alerts related to events affecting regulated products, such as safety events, product quality issues, supply disruptions, or other significant public health signals. Information obtained through this Request for Information (RFI) will assist the Government in determining the availability of industry capabilities, potential technical integration approaches, and possible cost models associated with providing real-time signal feeds to FDA systems. This RFI is issued for market research purposes only and does not constitute a solicitation for proposals or a commitment by the Government to issue a solicitation in the future. steven gagnon Alternative

Point of Contact Philip Frame Contracting (No Street Address

2) Rockville, MD 20857 USA to this opportunity. Vendor Day April 2026.pdf FDA Vendor Day Summary.pdf RFI - Enhanced Surveillance 3.16.2026.pdf